Boston Scientific Corporation (NYSE:BSX) Shares Bought by IFM Investors Pty Ltd

IFM Investors Pty Ltd lifted its stake in shares of Boston Scientific Corporation (NYSE:BSX) by 34.7% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 37,053 shares of the medical equipment provider’s stock after purchasing an additional 9,538 shares during the period. IFM Investors Pty Ltd’s holdings in Boston Scientific Corporation were worth $1,027,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also modified their holdings of BSX. Bronfman E.L. Rothschild L.P. raised its holdings in shares of Boston Scientific Corporation by 7.2% during the first quarter. Bronfman E.L. Rothschild L.P. now owns 5,041 shares of the medical equipment provider’s stock valued at $125,000 after buying an additional 338 shares during the last quarter. Guardian Life Insurance Co. of America increased its stake in shares of Boston Scientific Corporation by 0.9% during the first quarter. Guardian Life Insurance Co. of America now owns 5,266 shares of the medical equipment provider’s stock valued at $131,000 after acquiring an additional 49 shares during the period. Peddock Capital Advisors LLC acquired a new position in shares of Boston Scientific Corporation during the second quarter valued at approximately $201,000. Commerce Bank acquired a new position in shares of Boston Scientific Corporation during the first quarter valued at approximately $207,000. Finally, Los Angeles Capital Management & Equity Research Inc. acquired a new position in shares of Boston Scientific Corporation during the first quarter valued at approximately $215,000. 90.52% of the stock is currently owned by hedge funds and other institutional investors.

Several research firms have issued reports on BSX. BidaskClub lowered shares of Boston Scientific Corporation from a “hold” rating to a “sell” rating in a research report on Saturday, August 26th. Needham & Company LLC lifted their price target on shares of Boston Scientific Corporation from $30.00 to $32.00 and gave the stock a “buy” rating in a research report on Thursday, June 22nd. Stifel Nicolaus restated a “buy” rating and issued a $32.00 price target on shares of Boston Scientific Corporation in a research report on Sunday, July 30th. Zacks Investment Research cut shares of Boston Scientific Corporation from a “hold” rating to a “sell” rating in a research report on Tuesday, July 11th. Finally, Oppenheimer Holdings, Inc. reiterated a “hold” rating on shares of Boston Scientific Corporation in a research report on Wednesday, June 28th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $29.88.

In other Boston Scientific Corporation news, SVP John Bradley Sorenson sold 2,100 shares of the business’s stock in a transaction on Monday, July 31st. The shares were sold at an average price of $27.15, for a total transaction of $57,015.00. Following the completion of the sale, the senior vice president now owns 18,880 shares in the company, valued at approximately $512,592. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Daniel J. Brennan sold 92,158 shares of the business’s stock in a transaction on Tuesday, July 11th. The shares were sold at an average price of $27.48, for a total transaction of $2,532,501.84. Following the sale, the chief financial officer now owns 235,421 shares of the company’s stock, valued at approximately $6,469,369.08. The disclosure for this sale can be found here. Insiders sold a total of 275,257 shares of company stock valued at $7,512,394 in the last quarter. 0.74% of the stock is currently owned by company insiders.

ILLEGAL ACTIVITY NOTICE: “Boston Scientific Corporation (NYSE:BSX) Shares Bought by IFM Investors Pty Ltd” was originally posted by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this story can be accessed at https://stocknewstimes.com/2017/09/13/boston-scientific-corporation-bsx-shares-bought-by-ifm-investors-pty-ltd.html.

Boston Scientific Corporation (NYSE:BSX) traded up 0.052% during trading on Wednesday, reaching $29.025. 1,503,078 shares of the company’s stock were exchanged. Boston Scientific Corporation has a 52-week low of $19.67 and a 52-week high of $29.40. The stock’s 50 day moving average price is $27.10 and its 200 day moving average price is $26.43. The firm has a market cap of $39.83 billion, a P/E ratio of 51.923 and a beta of 1.09.

Boston Scientific Corporation (NYSE:BSX) last issued its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $0.32 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.31 by $0.01. The firm had revenue of $2.26 billion for the quarter, compared to the consensus estimate of $2.21 billion. Boston Scientific Corporation had a net margin of 9.04% and a return on equity of 23.62%. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.27 EPS. Equities research analysts anticipate that Boston Scientific Corporation will post $1.26 EPS for the current fiscal year.

Boston Scientific Corporation Company Profile

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology.

Institutional Ownership by Quarter for Boston Scientific Corporation (NYSE:BSX)

Receive News & Ratings for Boston Scientific Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply